Continuity, confidentiality, and confidence – preserved
Following Thermo Fisher’s acquisition of Clario, it’s business as usual for our CRO customers. Your projects, contracts, data protections and dedicated account teams remain fully in place, with added backing from Thermo Fisher’s global resources to further strengthen our support.
Learn more about our commitment to continuity for CRO customers.
OVERVIEW
Elevate your clinical trial success
In today’s competitive clinical research landscape, CROs need trusted partners who enhance their capabilities, streamline operations, and ensure the highest quality data. Clario offers partnerships with CROs of all sizes to strengthen your service offerings, helping you win more business and deliver successful trials with speed and precision.
50+
years of experience
30,000+
clinical trial opportunities
700+
FDA and EMA new drug approvals
100+
countries
70%
of FDA and EMA new drug approvals since 2015
24/7
customer and patient support
SOLUTIONS AND EXPERTISE
At Clario, we simplify the difficult –
Enhance your trial offerings with comprehensive endpoint solutions
CROs partnering with Clario gain access to a full suite of integrated efficacy, safety, and quality-of-life assessments across all therapeutic areas and trial designs. Our expertise in Imaging, eCOA, Cardiac, or Respiratory endpoints enables the delivery of high-quality, regulatory-grade data that enhances trial outcomes and supports seamless regulatory submissions.
Deep scientific and regulatory expertise
Early scientific engagement is key.
With a dedicated team of over 140 scientific and medical experts, Clario provides unmatched support in endpoint selection, study design, and regulatory compliance. Our expertise helps CROs navigate evolving global regulations, optimize their sponsors’ endpoint strategy, and help trials remain on track for approval.
Click on one of the solution areas below to see the related team.
Drive efficiency and operational excellence
Clario’s global operational teams provide responsive, scalable support, allowing CROs to optimize workflows, reduce trial complexity, and accelerate study timelines. Our advanced technology platform seamlessly integrates with CRO systems, ensuring smooth collaboration, efficient data management, and streamlined trial execution.
A competitive advantage for CROs
By integrating Clario’s endpoint solutions into their service offerings, CROs can differentiate themselves in the market, enhance their credibility with sponsors, and secure more trial opportunities. Our commitment to data integrity, scientific excellence, and patient-centric solutions makes Clario the ideal partner for all CROs looking to deliver best-in-class clinical trials.
Vast therapeutic area expertise
CROs gain a competitive edge by partnering with Clario’s unparalleled therapeutic expertise spanning neurology, oncology, cardiovascular, metabolic disorders, respiratory, and more. Our broad experience ensures that no matter the indication, your trial benefits from tailored, scientifically rigorous endpoint solutions that meet regulatory expectations.
Providing seamless support across all trial phases
Study design and startup
- Expert consultation on endpoint selection and trial strategy
- Rapid study startup with proven processes and technology integration
- Regulatory insights to streamline approvals
Trial execution and monitoring
- Scalable, high-quality data collection and analysis
- Advanced analytics for real-time decision-making
- Seamless collaboration through integrated technology platforms
Regulatory and market access support
- Regulatory-grade data to support successful submissions
- Insights to enhance payer and reimbursement strategies
- Patient-centric outcomes to demonstrate real-world impact
FAQs
What clinical trial services does Clario provide to CROs?
Clario provides CROs with integrated clinical trial endpoint solutions, including imaging, eCOA, cardiac, respiratory, and digital motion endpoints. These services are supported by scientific experts, global operations, and regulatory‑grade data standards to help CROs execute trials efficiently and compliantly.
How does Clario help CROs improve trial quality and efficiency?
Clario improves trial quality by combining early scientific engagement, validated endpoint technologies, and scalable global operations. This approach reduces operational complexity, accelerates timelines, and helps ensure high‑quality data suitable for regulatory submission.
Can Clario integrate with existing CRO technology platforms?
Yes. Clario’s technology platform is designed to integrate seamlessly with CRO systems, enabling efficient data exchange, streamlined workflows, and coordinated trial execution across global studies.
Does Clario support global, multi‑region CRO trials?
Clario supports CRO‑led trials in over 100 countries, providing global operational teams, multilingual patient support, and regulatory expertise aligned with FDA, EMA, and other regional authorities.
How does partnering with Clario help CROs win more sponsors?
By offering validated endpoint solutions, regulatory confidence, and operational scale, CROs partnering with Clario can differentiate their services, increase sponsor trust, and compete for larger, more complex clinical trials.
Strengthen delivery with integrated endpoints
Tell us how you deliver trials today. We’ll map the right endpoint support to reduce friction, protect timelines, and keep sponsor confidence high.
Reach out today and can route you to a team that supports CRO workflows and confidentiality.